Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 7/20 | 0.71 |
| ▸ | THRA | P10827 | 5/20 | 0.71 |
| ▸ | TSHR | P16473 | 2/20 | 0.55 |
| ▸ | MEN1 | O00255 | 2/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.53 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.46 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.43 |
| ▸ | ACR | P10323 | 1/20 | 0.43 |
| ▸ | CNR1 | P21554 | 4/20 | 0.42 |
| ▸ | CNR2 | P34972 | 2/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | PPARG | P37231 | 1/20 | 0.40 |
| ▸ | PPARA | Q07869 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4475068 | 0.83 | THRB (1.00) | THRBTHRAMEN1KMT2AALOX5 | |
| SCHEMBL111780 | 0.83 | THRB (1.00) | THRBTHRAMEN1KMT2AALOX5 | |
| SCHEMBL28432248 | 0.83 | THRB (1.00) | THRBTHRAMEN1KMT2AALOX5 | |
| SCHEMBL6931222 | 0.83 | THRB (1.00) | THRBTHRAMEN1KMT2AALOX5 | |
| SCHEMBL2289077 | 0.83 | THRB (1.00) | THRBTHRAMEN1KMT2AALOX5 | |
| SCHEMBL11576159 | 0.83 | THRB (1.00) | THRBTHRAMEN1KMT2AALOX5 | |
| SCHEMBL28933729 | 0.83 | THRB (1.00) | THRBTHRAMEN1KMT2AALOX5 | |
| SCHEMBL29689968 | 0.83 | THRB (1.00) | THRBTHRAMEN1KMT2AALOX5 | |
| SCHEMBL28428731 | 0.83 | THRB (1.00) | THRBTHRAMEN1KMT2AALOX5 | |
| SCHEMBL2574997 | 0.83 | THRB (0.60) | THRBTHRATSHRMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110366703-B | Substrate pretreatment composition for nanoimprint lithography | 佳能株式会社 | 2023-11-14 | — | — | CN | claimed |
| US-20260077385-A1 | FILM FORMING METHOD, CURABLE COMPOSITION, AND ARTICLE MANUFACTURING METHOD | CANON KABUSHIKI KAISHA (JP) | 2026-03-19 | — | — | US | disclosed |
| US-20260042932-A1 | COMPOSITION, PATTERN FORMING METHOD, AND ARTICLE MANUFACTURING METHOD | CANON KK (JP) | 2026-02-12 | — | — | US | disclosed |
| EP-4538019-A1 | CURABLE COMPOSITION, METHOD FOR FORMING INVERTED PATTERN, METHOD FOR FORMING FILM, AND METHOD FOR PRODUCING ARTICLE | CANON KABUSHIKI KAISHA (JP) | 2025-04-16 | — | — | EP | disclosed |
| US-20250109253-A1 | CURABLE COMPOSITION, INVERTED PATTERN FORMING METHOD, FILM FORMING METHOD, AND ARTICLE MANUFACTURING METHOD | CANON KABUSHIKI KAISHA (JP) | 2025-04-03 | — | — | US | disclosed |
| CN-119343746-A | Curable composition, reverse pattern forming method, film forming method, and article manufacturing method | 佳能株式会社 | 2025-01-21 | — | — | CN | disclosed |
| US-20240392148-A1 | PATTERN FORMING METHOD AND ARTICLE MANUFACTURING METHOD | CANON KABUSHIKI KAISHA (JP) | 2024-11-28 | — | — | US | disclosed |
| CN-118648087-A | Film forming method and article manufacturing method | 佳能株式会社 | 2024-09-13 | — | — | CN | disclosed |
| CN-117461112-A | Curable composition, film forming method, and method for producing product | 佳能株式会社 | 2024-01-26 | — | — | CN | disclosed |
| WO-2023243484-A1 | CURABLE COMPOSITION, METHOD FOR FORMING INVERTED PATTERN, METHOD FOR FORMING FILM, AND METHOD FOR PRODUCING ARTICLE | キヤノン株式会社 | 2023-12-21 | — | — | WO | disclosed |
| CN-110366703-B | Substrate pretreatment composition for nanoimprint lithography | 佳能株式会社 | 2023-11-14 | — | — | CN | disclosed |
| WO-2023162519-A1 | PATTERN FORMING METHOD AND METHOD FOR PRODUCING ARTICLE | キヤノン株式会社 | 2023-08-31 | — | — | WO | disclosed |
| WO-2023153123-A1 | FILM FORMATION METHOD AND ARTICLE MANUFACTURING METHOD | キヤノン株式会社 | 2023-08-17 | — | — | WO | disclosed |
| WO-2023112512-A1 | FILM FORMING METHOD AND METHOD FOR PRODUCING ARTICLE | キヤノン株式会社 | 2023-06-22 | — | — | WO | disclosed |
| WO-2022259748-A1 | CURABLE COMPOSITION, FILM FORMATION METHOD, AND ARTICLE MANUFACTURING METHOD | キヤノン株式会社 | 2022-12-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260077385-A1 | FILM FORMING METHOD, CURABLE COMPOSITION, AND ARTICLE MANUFACTURING METHOD | EEF1D, RHOA, YWHAH | THRB 4240/4885THRA 4234/4885TSHR 4527/4885 |
| US-20260042932-A1 | COMPOSITION, PATTERN FORMING METHOD, AND ARTICLE MANUFACTURING METHOD | SMCHD1, PIM1, PIM2 | THRB 4787/4885THRA 4577/4885TSHR 4809/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.